PureTech Health (NASDAQ:PRTC) Shares Gap Down to $27.93

PureTech Health plc (NASDAQ:PRTC)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $27.93, but opened at $27.05. PureTech Health shares last traded at $27.05, with a volume of 106 shares.

PureTech Health Stock Down 3.2 %

The firm’s 50 day simple moving average is $26.11 and its two-hundred day simple moving average is $23.40.

Institutional Investors Weigh In On PureTech Health

An institutional investor recently bought a new position in PureTech Health stock. Jane Street Group LLC acquired a new stake in shares of PureTech Health plc (NASDAQ:PRTC) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 8,343 shares of the company’s stock, valued at approximately $269,000. Hedge funds and other institutional investors own 0.04% of the company’s stock.

PureTech Health Company Profile

PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.